Clinical Trial Update: Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the efficacy of epoetin alfa deep tank for treating anemia in patients with chronic kidney disease receiving hemodialysis. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Amgen | Conditions: Nephrology | Phase 3 | Status: COMPLETED